Prevention of paroxysmal tachycaria of Wolff-Parkinson-White Syndrome with combined propranolol and quinidine therapy.
D000328:Adult; D004357:Drug Synergism; D006801:Humans; D008297:Male; D011433:Propranolol / Q000627:therapeutic use*; D011802:Quinidine / Q000627:therapeutic use*; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy*; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy*
D011433:Propranolol; D011802:Quinidine